← Open Payments lookup

MELISSA GIONFRIDDO: Open Payments

NPI 1154553956 · MADISON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,729 in 84 payments from 17 companies in 2025. Trend: 2023 $1,632 · 2024 $1,561 · 2025 $1,729

Food & beverage: $1,729
CompanyPaymentsAmount
ABBVIE INC.25$448
Novo Nordisk Inc9$180
GlaxoSmithKline, LLC.10$166
Lilly USA, LLC6$157
Otsuka America Pharmaceutical, Inc.6$136
Vanda Pharmaceuticals Inc.4$127
Astellas Pharma US Inc5$126
Amgen Inc.4$73
AstraZeneca Pharmaceuticals LP4$71
Exact Sciences Corporation2$52

Products named: VRAYLAR, MOUNJARO, UBRELVY, REXULTI, TRELEGY ELLIPTA, FANAPT, Veozah, Wegovy.

Industry payments across CT — which companies pay providers there.